InflaRx (IFRX) Profit After Tax (2016 - 2026)

InflaRx's (IFRX) quarterly Profit After Tax came in at -$6.5 million in Q1 2026, up 25.13% year-on-year from -$5.2 million in Q1 2025, and up 46.98% quarter-over-quarter from -$12.3 million in Q4 2025.

InflaRx (IFRX) Profit After Tax (2016 - 2026) Analysis & Trends

InflaRx has disclosed Profit After Tax across 11 years of filings, most recently posting -$6.5 million for Q1 2026.

  • Profit After Tax for Q1 2026 came in at -$6.5 million, up 25.13% year-over-year; the trailing twelve-month figure through Mar 2026 was -$49.5 million (down 2.62% YoY), and the FY2025 annual result was -$53.1 million, down 7.83% from the prior year.
  • Profit After Tax came in at -$6.5 million for Q1 2026 at InflaRx, up from -$12.3 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $496582.6 in Q2 2022 to a low of -$7987.2 billion in Q3 2022.
  • The 5-year median for Profit After Tax is -$11.9 million (2023), against an average of -$469.8 billion.
  • Across the five-year window, Profit After Tax plunged 56183593.8% in 2022 and soared 100.0% in 2023, its largest moves.
  • InflaRx's Profit After Tax stood at -$8.2 million in 2022, then slumped by 109.31% to -$17.1 million in 2023, then surged by 68.13% to -$5.5 million in 2024, then slumped by 126.07% to -$12.3 million in 2025, then soared by 46.98% to -$6.5 million in 2026.
  • The last three Profit After Tax figures came in at -$6.5 million (Q1 2026), -$12.3 million (Q4 2025), and -$14.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -26.94 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -2.97 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 30.90 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -14.46 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -3.63 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -753,254.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 1.03 Bn
9 Abivax 94.26 Bn 94.26 Bn - -56.74 Mn
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40 -6.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.55 Mn
Dec 31, 2025 -12.35 Mn
Sep 30, 2025 -14.33 Mn
Jun 30, 2025 -16.32 Mn
Mar 31, 2025 -8.75 Mn
Dec 31, 2024 -5.46 Mn
Sep 30, 2024 -19.16 Mn
Jun 30, 2024 -14.91 Mn
Mar 31, 2024 -10.49 Mn
Dec 31, 2023 -17.14 Mn
Sep 30, 2023 -8.11 Mn
Jun 30, 2023 -8.93 Mn
Mar 31, 2023 -11.90 Mn
Dec 31, 2022 -8.19 Mn
Sep 30, 2022 -7,987.22 Bn
Jun 30, 2022 496,582.57
Mar 31, 2022 -15.72 Mn
Dec 31, 2021 -14.49 Mn
Sep 30, 2021 -14.22 Mn
Jun 30, 2021 17.80 Mn